| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |